Cargando…

Genome profiling of chronic myelomonocytic leukemia: frequent alterations of RAS and RUNX1 genes

BACKGROUND: Chronic myelomonocytic leukemia (CMML) is a hematological disease close to, but separate from both myeloproliferative disorders (MPD) and myelodysplastic syndromes and may show either myeloproliferative (MP-CMML) or myelodysplastic (MD-CMML) features. Not much is known about the molecula...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gelsi-Boyer, Véronique, Trouplin, Virginie, Adélaïde, José, Aceto, Nicola, Remy, Virginie, Pinson, Stephane, Houdayer, Claude, Arnoulet, Christine, Sainty, Danielle, Bentires-Alj, Mohamed, Olschwang, Sylviane, Vey, Norbert, Mozziconacci, Marie-Joëlle, Birnbaum, Daniel, Chaffanet, Max
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2588460/ https://www.ncbi.nlm.nih.gov/pubmed/18925961 http://dx.doi.org/10.1186/1471-2407-8-299

Ejemplares similares

Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias
por: Rocquain, Julien, et al.
Publicado: (2010)

Rare mutations in DNMT3A in myeloproliferative neoplasms and myelodysplastic syndromes
por: Brecqueville, M, et al.
Publicado: (2011)

Revisiting gene mutations and prognosis of ex-M6a-acute erythroid leukemia with regard to the new WHO classification
por: Cervera, N, et al.
Publicado: (2017)

Mutations and deletions of the SUZ12 polycomb gene in myeloproliferative neoplasms
por: Brecqueville, M, et al.
Publicado: (2011)

Erythroleukemia: Classification
por: Cervera, Nathalie, et al.
Publicado: (2023)

Drug response profiling can predict response to ponatinib in a patient with t(1;9)(q24;q34)-associated B-cell acute lymphoblastic leukemia
por: Collette, Y, et al.
Publicado: (2015)

Role of ASXL1 and TP53 mutations in the molecular classification and prognosis of acute myeloid leukemias with myelodysplasia-related changes
por: Devillier, Raynier, et al.
Publicado: (2015)

Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases
por: Gelsi-Boyer, Véronique, et al.
Publicado: (2012)

Myeloid malignancies: mutations, models and management
por: Murati, Anne, et al.
Publicado: (2012)

Targeting Protein-Tyrosine Phosphatases in Breast Cancer
por: Aceto, Nicola, et al.
Publicado: (2012)

Multicolour-banding fluorescence in situ hybridisation (mbanding-FISH) to identify recurrent chromosomal alterations in breast tumour cell lines
por: Letessier, A, et al.
Publicado: (2005)

Multiple cytogenetics forms of KMT2A amplification and jumping translocation in a case of myelodysplastic syndrome
por: Ittel, Antoine, et al.
Publicado: (2021)

Spliceosome mutations in myelodysplastic syndromes and chronic myelomonocytic leukemia
por: Chesnais, Virginie, et al.
Publicado: (2012)

Can phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibition ERase them all?
por: Meyer, Dominique S, et al.
Publicado: (2010)

Co-expression of HER2 and HER3 receptor tyrosine kinases enhances invasion of breast cells via stimulation of interleukin-8 autocrine secretion
por: Aceto, Nicola, et al.
Publicado: (2012)

8q24 Cancer Risk Allele Associated with Major Metastatic Risk in Inflammatory Breast Cancer
por: Bertucci, François, et al.
Publicado: (2012)

Azacitidine Plus Venetoclax for the Treatment of Relapsed and Newly Diagnosed Acute Myeloid Leukemia Patients
por: Garciaz, Sylvain, et al.
Publicado: (2022)

Hippo inactivation feeds tumor-initiating cells
por: Duss, Stephan, et al.
Publicado: (2012)

Protein Tyrosine Phosphatase SHP2 Controls Interleukin-8 Expression in Breast Cancer Cells
por: Amante, Romain J., et al.
Publicado: (2022)

Early but not late pregnancy induces lifelong reductions in the proportion of mammary progesterone sensing cells and epithelial Wnt signaling
por: Meier-Abt, Fabienne, et al.
Publicado: (2014)

Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancers
por: Letessier, Anne, et al.
Publicado: (2006)

Feed‐forward loops between metastatic cancer cells and their microenvironment—the stage of escalation
por: Baumann, Zora, et al.
Publicado: (2022)

A chemogenomic approach to identify personalized therapy for patients with relapse or refractory acute myeloid leukemia: results of a prospective feasibility study
por: Collignon, A., et al.
Publicado: (2020)

‘The charmingest place’: non-coding RNA, lineage tracing, tumor heterogeneity, metastasis and metabolism - new methods in mammary gland development and cancer: the fifth ENBDC Workshop
por: Clarke, Robert B, et al.
Publicado: (2013)

The M-current works in tandem with the persistent sodium current to set the speed of locomotion
por: Verneuil, Jérémy, et al.
Publicado: (2020)

Methods in Mammary Gland Development and Cancer: the second ENDBC meeting - intravital imaging, genomics, modeling and metastasis
por: Stingl, John, et al.
Publicado: (2010)

New methods in mammary gland development and cancer: proteomics, epigenetics, symmetric division and metastasis
por: Bentires-Alj, Mohamed, et al.
Publicado: (2012)

Thirteenth Annual ENBDC Workshop: Methods in Mammary Gland Biology and Breast Cancer
por: Twigger, Alecia-Jane, et al.
Publicado: (2022)

Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization
por: Sabatier, Renaud, et al.
Publicado: (2014)

Myelomonocytic skewing in chronic myelomonocytic leukemia: phenotypic, molecular and biologic features and impact on survival
por: Geissler, Klaus, et al.
Publicado: (2021)

Trpm5 channels encode bistability of spinal motoneurons and ensure motor control of hindlimbs in mice
por: Bos, Rémi, et al.
Publicado: (2021)

It's all in the details: methods in breast development and cancer
por: Bentires-Alj, Mohamed, et al.
Publicado: (2009)

The devil is in the methods: lineage tracing, functional screens and sequencing, hormones, tumour-stroma interactions, and expansion of human breast tumours as xenografts
por: dM Vivanco, María, et al.
Publicado: (2011)

Signaling pathway switch in breast cancer
por: Guille, Arnaud, et al.
Publicado: (2013)

SMARCB1/INI1 germline mutations contribute to 10% of sporadic schwannomatosis
por: Rousseau, Guillaume, et al.
Publicado: (2011)

Tropheryma whipplei, the Agent of Whipple's Disease, Affects the Early to Late Phagosome Transition and Survives in a Rab5- and Rab7-Positive Compartment
por: Mottola, Giovanna, et al.
Publicado: (2014)

Twelfth Annual ENBDC Workshop: Methods in Mammary Gland Biology and Breast Cancer
por: Charifou, Elsa, et al.
Publicado: (2021)

RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia
por: Lipka, Daniel B., et al.
Publicado: (2017)

Coxiella burnetii lipopolysaccharide blocks p38α-MAPK activation through the disruption of TLR-2 and TLR-4 association
por: Conti, Filippo, et al.
Publicado: (2015)

Down-Regulation of ECRG4, a Candidate Tumor Suppressor Gene, in Human Breast Cancer
por: Sabatier, Renaud, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ft03glamucrnil6q7jda5kqk3u